Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
TEVA similar filings
- 25 Jul 13 Teva and Lonza Announce Mutual Decision to Discontinue Biologics Joint Venture
- 23 Jul 13 Live Filing
- 18 Jul 13 Current report (foreign)
- 10 Jul 13 Teva Completes Acquisition of MicroDose
- 9 Jul 13 Live Filing
- 1 Jul 13 Live Filing
- 24 Jun 13 Teva launches generic version of Viagra® (sildenafil) in countries across Europe
Filing view
External links
Teva Completes Acquisition of MicroDose
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced that it has completed the acquisition of effectively 100% of the outstanding shares of MicroDose for $40 million on July 8, 2013. The transaction was funded with cash on hand.